Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Science Track

External Validation of Therapy Response Interpretation Criteria (Hopkins Criteria) with inter-reader reliability, accuracy and Progression free survival outcomes.

Ayse Tuba Karagulle Kendi, David Brandon, Jeffrey Switchenko, J Wadsworth, Mark El-Deiry, Nabil Saba, David Schuster and Rathan Subramaniam
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 2715a;
Ayse Tuba Karagulle Kendi
4Radiology Emory University Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Brandon
4Radiology Emory University Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Switchenko
1Department of Biostatistics & Bioinformatics Emory University Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Wadsworth
3Otolaryngology, Head and Neck Surgery Emory University Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark El-Deiry
3Otolaryngology, Head and Neck Surgery Emory University Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nabil Saba
2Hematology Oncology Emory University Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Schuster
4Radiology Emory University Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rathan Subramaniam
5The Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2715a

Objectives Reliable assessment of PET/CT post-therapy involves reproducible and systematic reporting. A recently introduced response criteria (Hopkins Criteria) has demonstrated promising results in the assessment of head and neck cancer (1). In this study our aim is to re-validate the Hopkins interpretation system, using an external head and neck cancer patients, to assess therapy response and progression free survival in head and neck squamous cell cancer patients (HNSCC).

Methods The study included 69 biopsy proven HNSCC patients who underwent post-therapy PET/CT between 5-24 weeks after completion of therapy. PET/CT images were interpreted by one nuclear medicine physician and one nuclear radiologist independently. The studies scored according to Hopkins Criteria for overall, right neck, left neck, and primary tumor site assessment. Scores 1, 2, 3 were considered as negative and scores 4 and 5 were considered as positive for tumor. Inter-reader variability was assessed using percent agreement and Kappa statistics. Progression-free survival (PFS) was analyzed by Kaplan-Meier plots.

Results Of the 69 patients in the study, 59 (85.5%) were male, 10 (14.5%) were female. Mean age was 62.8 years. There was 91.3%, 97.6%, 97.6%, 91.3% agreement between the readers for overall, right neck, left neck, and primary tumor site response scores, respectively. The corresponding k coefficients were, 0.57, 0.84, 0.78, 0.65 for overall, right neck, left neck, and primary tumor site, respectively. Cox multivariate regression analysis showed positive primary tumor site scores and overall scores were associated with a higher risk of progression (p<0.05).

Conclusions External validation of Hopkins Criteria shows excellent inter-reader agreement and prediction of PFS in HNSCC patients.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
External Validation of Therapy Response Interpretation Criteria (Hopkins Criteria) with inter-reader reliability, accuracy and Progression free survival outcomes.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
External Validation of Therapy Response Interpretation Criteria (Hopkins Criteria) with inter-reader reliability, accuracy and Progression free survival outcomes.
Ayse Tuba Karagulle Kendi, David Brandon, Jeffrey Switchenko, J Wadsworth, Mark El-Deiry, Nabil Saba, David Schuster, Rathan Subramaniam
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 2715a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
External Validation of Therapy Response Interpretation Criteria (Hopkins Criteria) with inter-reader reliability, accuracy and Progression free survival outcomes.
Ayse Tuba Karagulle Kendi, David Brandon, Jeffrey Switchenko, J Wadsworth, Mark El-Deiry, Nabil Saba, David Schuster, Rathan Subramaniam
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 2715a;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Science Track

  • Usefulness of the total lesion glycolysis (TLG) ratio in predicting the therapeutic effect of head and neck cancer-A novel parameter-
  • Early response monitoring with 18F-FDG PET/CT after Chemoradiotherapy with Cetuximab in head and neck Squamous Cell Carcinoma Patients (HNSCC)
  • Clinical management and outcomes in differentiated thyroid cancer patients with positive postoperative-stimulated thyroglobulin antibody and undetectable postoperative-stimulated thyroglobulin at initial 131I ablation after total thyroidectomy
Show more Oncology, Clinical Science Track

MTA I: Head and Neck Posters

  • Dual phase parathyroid scintigraphy: Improved accuracy with quantitative SPECT
  • Relationships between preoperative FMISO- and FDG-PET parameters and the prognosis in patients with oral squamous cell carcinoma
Show more MTA I: Head and Neck Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire